II
MIRM icon

Inspire Investing’s Mirum Pharmaceuticals MIRM Stock Holding History

Inspire Investing’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181 Sell
2
-2,203
-100% -$221K ﹤0.01% 1220
2026
Q1 		$204K Buy
+2,205
New +$207K 0.01% 884
2025
Q4 		– Hold
0
– – – 1096

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Inspire Investing's MIRM Position: Q2 2026 in Review

Inspire Investing reduced its Mirum Pharmaceuticals (MIRM) stake by 100% in Q2 2026, selling an estimated $221K and leaving 2 shares worth $181. The position accounts for ﹤0.01% of the portfolio, ranked #1220.

Inspire Investing first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. The position peaked at $204K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Inspire Investing held 2 shares of Mirum Pharmaceuticals worth $181 as of Q2 2026.
  • Inspire Investing sold 2,203 Mirum Pharmaceuticals shares in Q2 2026, an estimated $221K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1220 holding.
  • Inspire Investing first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Inspire Investing's Mirum Pharmaceuticals position peaked at $204K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.